Ketryx’s comments to FDA on GenAI-enabled medical devices, covering risk, benchmarking, postmarket monitoring, PCCPs and third-party foundation models.
Ketryx Comments to FDA on the Regulation of Generative AI-Enabled Medical Devices
calendar_today
November 4, 2026
domain
ketryx